EARLY INVASIVE BREAST CANCER. ANALYSIS OF CLINICOPATHOLOGICAL PARAMETERS CORRELATED WITH EARLY METASTASIS
早期浸润性乳腺癌。
基本信息
- 批准号:16590266
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1)We have retrospectively re-evaluated 45 cases of non-invasive ductal carcinomas, which had been diagnosed on core needle biopsy (CNB) specimen (16 gouge). At subsequent resected (operative) specimen, 16 (36%) cases slowed invasive ductal carcinoma components, and in addition, 4 of them had lymph nodes metastases. Thus, that CNB may not always be a good procedure to detect early invasive cancer.2)To evaluate early phase of metastases, special staining for elastic fibers as well as immunohistochemical analysis for endothelial cell markers had been performed. Lymph vessel invasion, detected by anti-D2-40 or anti-podplanin, were seen at the periphery of invasive carcinomas. Moderate to severe lymph vessel invasion could be detected even on routine H&E staining glass slides. Venous invasion could not be detected on H&E, on the other hand, it bad been only recognized by elastic fiber stains (ie. Masson-Goldner's procedure), and venous invasion was correlated well with patient survival.3)We have collected invasive ductal carcinomas with less than 10mm of maximum invasive diameter. About 200 cases had been collected, but we have never experienced the case with node positive, if the maximum diameter is less then 3mm. In addition, all of the cases with node positive and 3-4mm invasive components, had comedonecrosis and high grade nuclei in their noninvasive carcinoma components.4)cDNA microarray evaluation had been performed for invasive micropapillaxy carcinoma (IMPCa), because IMPCa may have a focus on early phase metastasis. IMIPCa had been considered to have the abnormalities for cell adhesion genes and/or genes in relation to cell polarity. Some of the had been comfirmed by additional immunostains.5)For detecting early invasive components more objectively, the usefulness of immunohistochemistry may be limited. However, basal cell markers, especially cytokeratin 5, 6, 14, can be used to making differential diagnosis between benign and malignant papillary lesions.
1)回顾性分析了45例非浸润性导管癌患者的临床资料,这些患者均经空芯针穿刺活检(CNB)标本(16个凿孔)确诊。16例(36%)病例在随后的切除(手术)标本中减缓了浸润性导管癌成分,此外,其中4例有淋巴结转移。因此,CNB可能并不总是检测早期浸润性癌的良好方法。2)为了评估早期转移,进行了弹性纤维的特殊染色以及内皮细胞标志物的免疫组化分析。抗D2 -40或抗podplanin检测的淋巴管浸润可见于浸润性癌的周围。即使在常规H&E染色载玻片上也可以检测到中度至重度淋巴管浸润。静脉侵犯在H&E上不能被发现,另一方面,它只能被弹性纤维染色(即弹性纤维染色)识别。Masson-Goldner手术),静脉浸润与患者生存率相关。3)我们收集了最大浸润直径小于10 mm的浸润性导管癌。收集了近200例淋巴结转移病例,但我们从未遇到过最大直径小于3 mm的淋巴结阳性病例。此外,所有淋巴结阳性和浸润性成分3- 4 mm的病例,其非浸润性癌成分中均出现粉刺坏死和高级别细胞核。4)对浸润性微乳头状癌(IMPCa)进行了cDNA微阵列评估,因为IMPCa可能集中于早期转移。IMIPCa被认为存在细胞粘附基因和/或与细胞极性相关的基因异常。5)免疫组化在早期浸润成分检测中的作用可能有限。而基底细胞标志物,尤其是细胞角蛋白5、6、14可用于乳头状病变良恶性的鉴别诊断。
项目成果
期刊论文数量(41)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Collaboration of breast cancer clinic and genetic counseling division for BRCA1 and BRCA2 mutation family in Japan.
- DOI:10.1007/bf02967998
- 发表时间:2004-01-01
- 期刊:
- 影响因子:0
- 作者:Takeda, Motohiro;Ishida, Takanori;Ohuchi, Noriaki
- 通讯作者:Ohuchi, Noriaki
Pathological aspects of core needle biopsy for non-palpable breast lesions.
- DOI:10.2325/jbcs.12.272
- 发表时间:2005-01-01
- 期刊:
- 影响因子:0
- 作者:Usami, Shin;Moriya, Takuya;Ohuchi, Noriaki
- 通讯作者:Ohuchi, Noriaki
Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
雌激素响应指蛋白作为乳腺癌新的潜在生物标志物。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Suzuki T;Urano T;Inoue S et al.
- 通讯作者:Inoue S et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MORIYA Takuya其他文献
MORIYA Takuya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MORIYA Takuya', 18)}}的其他基金
Precancerous lesion of the breast: Establishment of disease entity and verification of clinic-pathological significance
乳腺癌前病变:疾病实体的建立及临床病理意义的验证
- 批准号:
22590340 - 财政年份:2010
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Early invasive cancer of the breast. Clinico-pathological analysis for establishment a new disease entity
乳腺癌的早期浸润性癌。
- 批准号:
12670153 - 财政年份:2000
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
- 批准号:
EP/Y03693X/1 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Research Grant
From single-cell transcriptomic to single-cell fluxomic: characterising metabolic dysregulations for breast cancer subtype classification
从单细胞转录组到单细胞通量组:表征乳腺癌亚型分类的代谢失调
- 批准号:
EP/Y001613/1 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Research Grant
Quad negative breast cancerに対する新たなプレシジョン・メディシン治療戦略
四阴性乳腺癌精准医学治疗新策略
- 批准号:
24K11748 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
- 批准号:
10110204 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Launchpad
ESR1 mutation profiling identifies potential drivers of metastatic breast cancer
ESR1 突变分析确定了转移性乳腺癌的潜在驱动因素
- 批准号:
MR/X018199/1 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Research Grant
Spatial-BrTME: Multicellular spatial dynamics of immunotherapy response in breast cancer
Spatial-BrTME:乳腺癌免疫治疗反应的多细胞空间动力学
- 批准号:
EP/Y014995/1 - 财政年份:2024
- 资助金额:
$ 2.11万 - 项目类别:
Research Grant
Decoding the impact of single cell mutational processes in triple negative breast cancer and high grade serous ovarian cancer
解读单细胞突变过程对三阴性乳腺癌和高级别浆液性卵巢癌的影响
- 批准号:
477662 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Operating Grants
225Ac-labeled anti-nectin-4 radioimmunoconjugate with/without immune checkpoint blockage in triple negative breast cancer.
225Ac 标记的抗 nectin-4 放射免疫缀合物,有/没有免疫检查点阻断治疗三阴性乳腺癌。
- 批准号:
488261 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Operating Grants
Identifying the molecular and environmental factors involved in promoting escape from breast cancer dormancy.
确定参与促进乳腺癌休眠逃逸的分子和环境因素。
- 批准号:
488246 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Operating Grants
The influence of ethical and social values on decision-making about participation in personalized breast cancer screening: A constructivist grounded theory study of South Asian people in Canada
伦理和社会价值观对参与个性化乳腺癌筛查决策的影响:针对加拿大南亚人的建构主义扎根理论研究
- 批准号:
491227 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Fellowship Programs